Molecular characterization of stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment

Infection Control and Hospital Epidemiology

Volumn 30, Issue 8, 2009, Pages 753-758

  Marzuillo, Carolina ^a   Giusti, Maria De ^a   Tufi, Daniela ^a   Giordano, Alessandra ^a   Cimmuto, Angela Del ^a   Quattrucci, Serena ^a   Mancini, Carlo ^a   Villari, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION MAPPING; STENOTROPHOMONAS MALTOPHILIA; WATER ANALYSIS; WATER CONTAMINATION;

ADOLESCENT; BACTERIAL TYPING TECHNIQUES; CROSS INFECTION; CYSTIC FIBROSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; EQUIPMENT CONTAMINATION; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; INFECTION CONTROL; MALE; MICROBIAL SENSITIVITY TESTS; RISK FACTORS; STENOTROPHOMONAS MALTOPHILIA; WATER MICROBIOLOGY;

EID: 67651124928     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/598683     Document Type: Article

References (28)

1. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002; 15:194-222.
2. Waters V, Ratjen F. Multidrug-resistant organisms in cystic fibrosis:management and infection-control issues. Expert Rev Anti Infect Ther 2006; 4: 807-819.
3. Davies JC, Rubin BK. Emerging and unusual gram-negative infections in cystic fibrosis. Semin Respir Crit Care Med 2007; 28:312-321.
4. Saiman L, Siegel J, Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 2003; 24(Suppl 5):S6-S52.
5. Saiman L, Siegel J, Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Am J Infect Control 2003; 31(Suppl 3):S1-S62.
6. Goss CH, Mayer-Hamblett N, Aitken ML, Rubenfeld GD, Ramsey BW. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax 2004; 59:955-959.
7. Goss CH, Otto K, Aitken ML, Rubenfeld GD. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am J Respir Crit Care Med 2002; 166:356-361.
8. Ballestero S, Virseda I, Escobar H, Suarez L, Baquero F. Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1995; 14:728-729.
9. Denton M. Stenotrophomonas maltophilia: an emerging problem in cystic fibrosis patients. Rev Med Microbiol 1997; 8:15-19.
10. Denton M, Todd NJ, Kerr KG, Hawkey PM, Littlewood JM. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinicalspecimens from patients with cystic fibrosis and associated environmental samples. J Clin Microbiol 1998; 36:1953-1958.
11. Valdezate S, Vindel A, Maiz L, Baquero F, Escobar H, Canton R. Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998. Emerg Infect Dis 2001; 7:113-122.
12. Krzewinski JW, Nguyen CD, Foster JM, Burns JL. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J Clin Microbiol 2001; 39:3597-3602.
13. Denton M, Todd NJ, Littlewood JM. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1996; 15:402-405.
14. Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 2004; 17:57-71.
15. Vonberg R-P, Gastmeier P. Isolation of infectious cystic fibrosis patients: results of a systematic review. Infect Control Hosp Epidemiol 2005; 26: 401-409.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility testing: 24th informational supplement: M100-S24. Wayne, PA: National Committee for Clinical Laboratory Standards; 2004.
17. Crispino M, Boccia MC, Bagattini M, Villari P, Triassi M, Zarrilli R. Molecular epidemiology of Stenotrophomonas maltophilia in a university hospital. J Hosp Infect 2002; 52:88-92.
18. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-2239.
19. Vu-Thien H, Moissenet D, Valcin M, Dulot C, Tournier G, Garbarg- Chenon A. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur J Clin Microbiol Infect Dis 1996; 15:876-879.
20. Nazik H, Ongen B, Erturan Z, Salcroglu M. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients. Jpn J Infect Dis 2007; 60: 82-86.
21. Tripkovic V, Muller-Premru M, Kalenic S, et al. Clustering of infections caused by different PFGE types of Stenotrophomonas maltophilia occurring simultaneously in a university hospital. J Hosp Infect 2001; 47:333- 335.
22. Lanotte P, Cantagrel S, Mereghetti L, et al. Spread of Stenotrophomonas maltophilia colonization in a pediatric intensive care unit detected by monitoring tracheal bacterial carriage and molecular typing. Clin Microbiol Infect 2003; 9:1142-1147.
23. Valdezate S, Vindel A, Davila PM, Del Saz BS, Baquero F, Canton R. High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 2004; 42:693- 699.
24. Gulmez D, Hascelik G. Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital. Clin Microbiol Infect 2005; 11:880-886.
25. Abbassi MS, Touati A, Achour W, et al. Stenotrophomonas maltophilia responsible for respiratory infections in neonatal intensive care unit: antibiotic susceptibility and molecular typing. Pathol Biol (Paris) (in press).
26. Berg G, Rosckot N, Smalla K. Genotyping and phenotypic relationship between clinical and environmental isolates of Stenotrophomonas maltophilia. J Clin Microbiol 1999; 37:3594-3600.
27. Denton M, Kerr KG. Molecular epidemiology of Stenotrophomonas maltophilia isolated from cystic fibrosis patients. J Clin Microbiol 2002; 40: 1884.
28. Yao JDC, Conly JM, Krajden M. Molecular typing of Stenotrophomonas (Xanthomonas) maltophilia by DNA macrorestriction analysis and random amplified polymorphic DNA analysis. J Clin Microbiol 1995; 33: 2195-2198.